This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Saturday, April 12, 2014
EASL Video/Hepatitis C - DAAs: continuing the advance towards a cure.
The final official EASL press conference
Hepatitis C - DAAs: continuing the advance towards a cure.
Published on Apr 12, 2014
Highlights data discussions on hepatitis C and progressions in treating genotype 4 and continuing towards a cure as well as Hepatocellular Carcinoma (HCC) and cirrhosis
Subscribe to:
Post Comments (Atom)
Where are any experiment research facilities my Mother can participate in. She has stage 2 hep c and can't afford the drug.
ReplyDeleteClinical Trials
ReplyDeleteTo learn more about Hepatitis C virus clinical trials or to find out if a study is enrolling patients in your area, please click here or
Click Here For Patient Assistance Programs